在进行生物标志物验证时，你更倾向于使用多反应监测还是抗体？ - Suppr

Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?

作者信息

Issaq Haleem J, Veenstra Timothy D

出版信息

Expert Rev Proteomics. 2008 Dec;5(6):761-3. doi: 10.1586/14789450.5.6.761.

DOI:10.1586/14789450.5.6.761

PMID:19086854

Abstract

摘要

相似文献

Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?

Expert Rev Proteomics. 2008 Dec;5(6):761-3. doi: 10.1586/14789450.5.6.761.

A 200-antibody microarray biochip for environmental monitoring: searching for universal microbial biomarkers through immunoprofiling.

Anal Chem. 2008 Nov 1;80(21):7970-9. doi: 10.1021/ac8008093. Epub 2008 Oct 7.

[Palmitoleic acid].

Nihon Rinsho. 1999 Dec;57 Suppl:776-8.

[Palmitoleic acid and oleic acid].

Nihon Rinsho. 2010 Jul;68 Suppl 7:849-52.

Biomarker assay development and validation for large molecules in bioanalysis: what are the challenges and how are they overcome?

Bioanalysis. 2012 Nov;4(22):2657-9. doi: 10.4155/bio.12.260.

Potential biomarkers for the diagnosis of stroke.

Expert Rev Cardiovasc Ther. 2009 Apr;7(4):389-93. doi: 10.1586/erc.09.9.

Verification and validation: whose responsibility, manufacturer or end user?

Ann Clin Biochem. 2011 Mar;48(Pt 2):93-4. doi: 10.1258/acb.2011.011008.

Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.

J Rheumatol. 2009 Aug;36(8):1792-9. doi: 10.3899/jrheum090347.

Biomarker validation: movement towards personalized medicine.

Expert Rev Mol Diagn. 2007 Sep;7(5):469-71. doi: 10.1586/14737159.7.5.469.

[State of the art and method validations: application to fidelity performance].

Ann Biol Clin (Paris). 2008 Nov-Dec;66(6):721-5. doi: 10.1684/abc.2008.0277.

引用本文的文献

Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens.

Oncotarget. 2018 Jul 20;9(56):30731-30747. doi: 10.18632/oncotarget.24578.

COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.

PLoS One. 2016 Aug 15;11(8):e0161129. doi: 10.1371/journal.pone.0161129. eCollection 2016.

Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Proteome Sci. 2009 Apr 6;7:15. doi: 10.1186/1477-5956-7-15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献